The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3Social Media CoordinatorOct 8, 20241 min readClick here to learn more and register!11-7-24 Davios Boston- Fruzaqla Dinner Talk Invitation.pdfDownload PDF • 847KB
NEW Event ~ A first-line treatment option for adults with anemia due to lower-risk MDS ~ 11/13/25 @ Capital Grille
Comments